HomeCompareARKD vs KMB

ARKD vs KMB: Dividend Comparison 2026

ARKD yields 331.30% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARKD wins by $2982.52M in total portfolio value
10 years
ARKD
ARKD
● Live price
331.30%
Share price
$18.00
Annual div
$59.63
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2982.57M
Annual income
$1,871,388,985.97
Full ARKD calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — ARKD vs KMB

📍 ARKD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARKDKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARKD + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARKD pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARKD
Annual income on $10K today (after 15% tax)
$28,160.24/yr
After 10yr DRIP, annual income (after tax)
$1,590,680,638.07/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, ARKD beats the other by $1,590,676,199.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARKD + KMB for your $10,000?

ARKD: 50%KMB: 50%
100% KMB50/50100% ARKD
Portfolio after 10yr
$1491.31M
Annual income
$935,697,104.15/yr
Blended yield
62.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

ARKD
No analyst data
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARKD buys
0
KMB buys
0
No recent congressional trades found for ARKD or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARKDKMB
Forward yield331.30%5.25%
Annual dividend / share$59.63$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$2982.57M$45.9K
Annual income after 10y$1,871,388,985.97$5,222.34
Total dividends collected$2874.57M$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: ARKD vs KMB ($10,000, DRIP)

YearARKD PortfolioARKD Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$43,830$33,129.70$11,314$614.45+$32.5KARKD
2$182,605$135,706.98$12,867$760.19+$169.7KARKD
3$723,786$528,399.04$14,713$945.27+$709.1KARKD
4$2,731,837$1,957,385.69$16,924$1,181.90+$2.71MARKD
5$9,827,643$6,904,577.89$19,596$1,486.64+$9.81MARKD
6$33,729,472$23,213,893.20$22,850$1,882.16+$33.71MARKD
7$110,550,761$74,460,226.89$26,849$2,399.80+$110.52MARKD
8$346,372,242$228,082,927.60$31,812$3,083.36+$346.34MARKD
9$1,038,485,851$667,867,552.02$38,033$3,994.72+$1038.45MARKD
10$2,982,568,847$1,871,388,985.97$45,918$5,222.34+$2982.52MARKD

ARKD vs KMB: Complete Analysis 2026

ARKDStock

ARKD is an actively managed ETF aiming to provide a more tampered price return for shares of ARK Innovation ETF (ticker: ARKK), over a one-year period starting each January. The fund aims to cut the downside risk in half in exchange for a capped upside potential after a 5% performance hurdle is reached. ARKK holds US and foreign equities focused on disruptive innovation themes such as genomics, AI, robotics, fintech. The fund holds shares of ARKK, sells at-the-money calls against the shares, buys at-the-money puts covering 50% of the funds NAV, and buys out-of-the-money calls with any available premium in order to provide upside exposure above the 5% hurdle. All returns are before fees and expenses, which reduce overall fund returns. ARKD shareholders do not receive dividends, if any, from shares of ARKK. The strategy works best for investors willing to hold shares the entire outcome period. Outcomes will differ for those buying/selling mid-period.

Full ARKD Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this ARKD vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARKD vs SCHDARKD vs JEPIARKD vs OARKD vs KOARKD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.